This exclusive report offers a detailed look at the global Computed Tomography Market. It assesses the transition to AI-based image reconstruction, the uptake of photon-counting and low-dose trends and the evolving regional insights. Essential components include competitive benchmarking, market dynamics and thorough evaluations of next-generation diagnostic and spectral-imaging lifecycles. The global Computed Tomography Market size was valued at US$ 5.91 Billion in 2025 and is poised to grow from US$ 6.23 Billion in 2026 to 12.67 Billion by 2033, growing at a CAGR of 6.73% in the forecast period (2026-2033). The analysis encompasses all major product categories, including high-slice systems, photon-counting CT, and portable configurations, while examining application-specific demand across oncology, cardiology, and trauma imaging. Regional breakdowns highlight North America's dominance and Asia-Pacific's exceptional growth trajectory.
Market Size (2026)
$5.91B
Projected (2033)
$12.67B
CAGR
6.73%
Published
April 2026
Select User License
Selected
PDF Report
USD 4,900
USD 3,200
The Computed Tomography Market is valued at $5.91B and is projected to grow at a CAGR of 6.73% during 2026 - 2033. North America holds the largest regional share, while Asia Pacific (18.4%–24.2% CAGR) is the fastest-growing market.
Study Period
2020 - 2033
Market Size (2026)
$5.91B
CAGR (2026 - 2033)
6.73%
Largest Market
North America
Fastest Growing
Asia Pacific (18.4%–24.2% CAGR)
Market Concentration
Medium
*Disclaimer: Major Players sorted in no particular order
Source: Claritas Intelligence — Primary & Secondary Research, 2026. All market size figures in USD unless otherwise stated.
Global Computed Tomography market valued at $5.91B in 2026, projected to reach $12.67B by 2033 at 6.73% CAGR
Key growth driver: Critical role in emergency care, oncology, cardiovascular assessment, and surgical planning (High, +2% CAGR impact)
North America holds the largest market share, while Asia Pacific (18.4%–24.2% CAGR) is the fastest-growing region
AI Impact: Artificial Intelligence is changing the Computed Tomography Market in a way. It is turning scanners into smart machines that can think for themselves.
11 leading companies profiled including GE Healthcare, Fujifilm Corporation, NeuroLogica Corp and 8 more
Artificial Intelligence is changing the Computed Tomography Market in a way. It is turning scanners into smart machines that can think for themselves. This is making a difference because it is helping to make better images from the data that the scanners collect. These new systems use kinds of computers called Convolutional Neural Networks to look at the data and make high quality images. They can even reduce the amount of radiation used by over 60 percent.
By 2026 these smart machines will be able to look at the images away and find any big problems like bleeding in the brain or blood clots in the lungs. They will be able to tell the doctor about these problems within seconds of the scan being done. This is helping to make the work of the doctor easier and more accurate. Artificial Intelligence is becoming an important tool for the healthcare system in 2026. It is helping to make sure that patients are in the position for their scans, which reduces mistakes.
The machines are using cameras to make sure the patient is in the correct spot. In 2026 Artificial Intelligence is also being used to make sure that all scans are safe. It is checking to make sure that every scan follows the rules for keeping patients safe. This is called the ALARA rule, which means keeping radiation low as possible. Artificial Intelligence is also being used to get information from scans. It can look at the tissues in the body. Measure things like calcium.
This is all happening because of the combination of computers and machines that can work on their own. The Computed Tomography Market is becoming a leader, in the move to make diagnosis faster safer and more accurate.
The Computed Tomography Market represents a well-established sector within medical imaging, encompassing scanner systems, software, service contracts, and refurbishment. The demand is primarily driven by emergency care, oncology staging and follow-up, cardiovascular assessment, trauma imaging, and pre-surgical planning. Purchasing decisions are influenced by factors such as throughput, image quality at reduced doses, uptime, and total cost of ownership over multi-year lifecycles. Health systems also assess CT platforms based on their interoperability with PACS/RIS, cybersecurity support, and the vendor's service footprint, as high utilization levels mean that downtime can significantly impact patient flow.
Current trends focus on enhancing diagnostic confidence while maximizing operational efficiency. Advanced reconstruction techniques, including AI-assisted algorithms, are being employed to minimize noise and artefacts, facilitate lower-dose protocols, and accelerate scan-to-report turnaround times. Cardiac CT is increasingly capturing clinical market share due to its rapid acquisition capabilities and superior motion handling, while oncology workflows prioritize standardized protocols and quantitative follow-up. Spectral techniques, such as dual-energy and newer detector architectures, are being utilized more frequently for material characterization and enhanced contrast, all without adding complexity for technologists.
Workflow automation is on the rise in areas such as patient positioning, protocol selection, and triage flagging, which helps maintain consistent imaging quality in busy departments. The portable and compact configurations are receiving more attention for specialized environments where space, infection control, or bedside access is critical.
| Year | Market Size (USD Billion) | Period |
|---|---|---|
| 2026 | $5.91B | Forecast |
| 2027 | $6.59B | Forecast |
| 2028 | $7.35B | Forecast |
| 2029 | $8.19B | Forecast |
| 2030 | $9.14B | Forecast |
| 2031 | $10.19B | Forecast |
| 2032 | $11.36B | Forecast |
| 2033 | $12.67B | Forecast |
Source: Claritas Intelligence — Primary & Secondary Research, 2026. All market size figures in USD unless otherwise stated.
Base Year: 2025The computed tomography market is strong because it plays a role in modern diagnosis especially in emergency care, cancer treatment, heart evaluations and surgery planning.
Advanced reconstruction techniques, including AI-assisted algorithms, are being employed to minimize noise and artefacts, facilitate lower-dose protocols, and accelerate scan-to-report turnaround times.
In 2026 the North America region is benefiting from reimbursement policies, such as Medicare's decision to pay more for coronary CT angiography.
The portable and compact configurations are receiving more attention for specialized environments where space, infection control, or bedside access is critical.
The computed tomography market faces challenges to concerns about radiation exposure and the need to balance image quality with patient safety.
They also face challenges like equipment downtime, maintenance needs and the requirement for skilled staff to operate complex imaging systems and interpret results.
Limited budgets in healthcare facilities can delay replacing CT equipment and upgrading existing infrastructure.
Opportunities in the computed tomography market come from expanding uses and improving workflows. The increase in imaging, cancer follow-ups and trauma care creates a demand for systems that enable faster scans and consistent image quality. Refurbished and modular CT solutions offer healthcare providers a way to enhance imaging capacity while managing budgets. The integration of CT imaging, into care pathways and multidisciplinary treatment planning also offers opportunities to boost utilization and long-term value across healthcare systems. Portable and mobile CT configurations present significant growth potential in intensive care units and stroke-response centers.
Emerging markets in Asia-Pacific and the Middle East offer substantial opportunities for diagnostic infrastructure expansion and oncology center development.
| Region | Market Share | Growth Rate |
|---|---|---|
| North America | 96.4% | 8.2%–11.5%% CAGR |
| Europe | 1.2% | 6.8%–9.2%% CAGR |
| Asia Pacific | 0.5% | 18.4%–24.2%% CAGRFastest |
| Latin America | 1% | 0%% CAGR |
| Middle East & Africa | 0.9% | 9.1%–12.8%% CAGR |
Source: Claritas Intelligence — Primary & Secondary Research, 2026.
GE Healthcare Fujifilm Corporation NeuroLogica Corp Neusoft Medical Systems Planmeca Oy Carestream Health Hitachi, Ltd Canon Medical Systems corporation Koninklijke Philips Siemens Healthineers Shenzhen Anke High-Tech Co. Koninklijke Philips. The competitive landscape is dominated by established multinational manufacturers with strong service networks and R&D capabilities. Recent approvals, including Neusoft's NeuViz P10 photon-counting CT in China, demonstrate accelerating innovation in next-generation detector technologies. Market consolidation and strategic partnerships continue to shape competitive positioning, with vendors differentiating through AI integration, dose optimization, and workflow automation solutions.
TOKYO, January 7, 2026 - FUJIFILM Corporation announces the launch of the "instax mini Evo Cinema" (mini Evo Cinema), a new model in the instax hybrid instant camera "Evo series". It will be available in Japan on January 30, 2026.
SHENYANG, China, August 27, 2025 /PR NEWSWIRE/ Neusoft Medical Systems today announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Products Administration (NMPA). This marks the first photon-counting CT approved in China, and the world's first wide-body system equipped with an 8-cm detector.
The Computed Tomography Market was valued at USD 5.91 billion in 2025 and is expected to reach USD 12.67 billion by 2033. This represents a steady compound annual growth rate (CAGR) of 6.73% over the forecast period, driven by increasing demand for diagnostic imaging in oncology, emergency departments, and cardiovascular assessment. See our market size analysis →
The CT market is growing at a CAGR of 6.73% through 2033. Key growth drivers include rising prevalence of chronic diseases requiring imaging diagnostics, adoption of AI-powered image reconstruction, demand for low-dose radiation protocols, and expansion of imaging infrastructure in emerging markets. Asia Pacific leads regional growth with CAGR of 18.4–24.2%. See our growth forecast → See our key growth drivers →
Scanner systems represent the largest segment within the CT market, encompassing diagnostic scanners, portable units, and specialized systems. Fastest growth is occurring in AI-integrated platforms and refurbished equipment segments, which address cost constraints and improve diagnostic efficiency in resource-limited healthcare settings. See our segment analysis →
North America is the largest regional market, driven by advanced healthcare infrastructure, high imaging throughput demand, and adoption of next-generation CT technologies. Asia Pacific is the fastest-growing region with CAGR of 18.4–24.2%, fueled by increasing healthcare spending, rising cancer incidence, and hospital modernization in China, India, and Japan. See our growth forecast → See our geography analysis →
Leading vendors include GE Healthcare, Fujifilm Corporation, NeuroLogica Corp (portable CT specialist), Neusoft Medical Systems, and Planmeca Oy. These companies compete on image quality at reduced doses, system uptime, throughput, software capabilities, and total cost of ownership over multi-year equipment lifecycles.
Primary growth drivers are increasing emergency department imaging volume and cancer staging demand worldwide. Secondary drivers include clinical adoption of AI-assisted image analysis, advancement in low-dose protocols reducing patient radiation exposure, and expansion of CT availability in rural and developing healthcare systems. See our key growth drivers →
Key challenges include high capital equipment costs limiting adoption in developing regions and regulatory compliance requirements increasing operating expenses. Additional restraints are ionizing radiation safety concerns, competition from alternative modalities like MRI and ultrasound, and pressure on healthcare budgets during economic downturns. See our market challenges → See our geography analysis →
Major opportunities include integration of artificial intelligence for automated diagnosis, development of photon-counting CT technology improving image resolution, and expansion into point-of-care portable CT systems for emergency and surgical environments. Emerging markets in Asia, Africa, and Latin America present significant growth potential as healthcare infrastructure investments accelerate. See our emerging opportunities →
How this analysis was conducted
Primary Research
Secondary Research
Access detailed analysis, data tables, and strategic recommendations.